Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Visual Agnosia01:12

Visual Agnosia

1.5K
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PhysioMotion Artifact: A task-driven EEG dataset with point-wise motion artifact annotations.

Scientific data·2026
Same author

Multimodal brain tumor segmentation and classification based on optimized DeepLabV3 + and fused fire module with self-attention.

European journal of medical research·2026
Same author

An Explainable Framework for the Relationship between Dementia and Metabolism Patterns.

ArXiv·2026
Same author

Unraveling the Autism Spectrum Heterogeneity: Insights From ABIDE I Database Using Data/Model-Driven Permutation Testing Approaches.

Brain and behavior·2026
Same author

Image-based AI tools in peripheral nerves assessment: Current status and integration strategies - A narrative review.

European journal of radiology·2025
Same author

Role of Large Language Models for Suggesting Nerve Involvement in Upper Limbs MRI Reports with Muscle Denervation Signs.

Clinical neuroradiology·2025

Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

Independent Component Analysis-Support Vector Machine-Based Computer-Aided Diagnosis System for Alzheimer's with

Laila Khedher1, Ignacio A Illán1, Juan M Górriz1

  • 11 Department of Signal Theory, Networking and Communications, University of Granada, Granada 18071, Spain.

International Journal of Neural Systems
|October 26, 2016
PubMed
Summary

This study introduces an advanced computer-aided diagnosis (CAD) system for early Alzheimer's disease (AD) detection using brain MRI scans. The novel system achieves high accuracy in classifying normal controls, mild cognitive impairment, and AD patients.

Keywords:
Alzheimer’s diseaseMRIcomputer-aided diagnosisindependent component analysissupport vector machines

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.5K

Related Experiment Videos

Last Updated: Mar 13, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.5K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Computer-aided diagnosis (CAD) systems are crucial for early Alzheimer's disease (AD) detection.
  • Existing CAD systems face challenges in interpretability and performance.
  • Brain magnetic resonance imaging (MRI) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort is a key data source.

Purpose of the Study:

  • To develop a fully automatic CAD system for early AD diagnosis using supervised learning.
  • To enhance CAD system performance and provide visual decision support.
  • To improve confidence in CAD system outputs for clinical application.

Main Methods:

  • A two-stage approach was employed: feature extraction using independent component analysis (ICA) on class mean images, followed by support vector machine (SVM) training and classification.
  • The system was applied to segmented brain MRI data from ADNI participants.
  • Graphical representations of classification features were generated for visual interpretability.

Main Results:

  • The CAD system achieved 89% accuracy (92% sensitivity, 86% specificity) in classifying normal controls (NC) and AD patients.
  • Classification accuracy for NC and mild cognitive impairment (MCI) was 79% (82% sensitivity, 76% specificity).
  • The system demonstrated 85% accuracy (85% sensitivity, 86% specificity) in differentiating MCI and AD patients.

Conclusions:

  • The proposed fully automatic CAD system offers optimal performance and visual interpretability for early AD diagnosis.
  • The method effectively classifies individuals across different stages of cognitive decline, including NC, MCI, and AD.
  • The visual output enhances user confidence and understanding of the diagnostic process.